Phase I Study of GSK461364, a Specific and Competitive Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Malignancies
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-2946
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2011
Authors
Publisher
American Association for Cancer Research (AACR)